Nature nanotechnology

Designing fat-based nanoparticles to deliver RNA medicines to the brain

Updated

Abstract

Hydroxyzine (HX) was identified as a promising scaffold for designing ionizable lipids that facilitate robust mRNA delivery to the brain.

  • Analysis of over 100 CNS-active drugs led to the identification of hydroxyzine as a candidate for improving brain-targeting properties.
  • HX1 liquid nanoparticles (LNPs) demonstrated effective mRNA delivery to the brain through various trafficking pathways.
  • Co-delivery of CRISPR mRNA and guide RNA using HX1 LNPs enabled efficient gene editing in mouse brains.
  • HX1 LNPs successfully delivered luciferase mRNA to the brain of a non-human primate.
  • Carrying Il10 mRNA, HX1 LNPs reduced radiation-induced brain injury in mice, suggesting potential for preventive treatment.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free